Literature DB >> 22752239

Reduced GABA concentration in attention-deficit/hyperactivity disorder.

Richard A E Edden1, Deana Crocetti, He Zhu, Donald L Gilbert, Stewart H Mostofsky.   

Abstract

CONTEXT: Attention-deficit/hyperactivity disorder (ADHD) is a developmental disorder characterized by a deficit in behavioral inhibition. Recent evidence also suggests a deficit in cortical inhibition via the GABA (γ-aminobutyric acid)-ergic system.
OBJECTIVE: To investigate the GABAergic component of ADHD using magnetic resonance spectroscopy.
DESIGN: Cross-sectional study.
SETTING: Participants were recruited through local schools, local pediatric and other community clinics, and through advertisement in regional publications. Magnetic resonance spectroscopy was performed within the research institute. PARTICIPANTS: Children (age range, 8-12 years) in a typically developing control group vs a group with ADHD were compared. MAIN OUTCOME MEASURES: J-difference-edited magnetic resonance spectroscopy at 3 T was used to measure GABA concentration in a volume that included primary somatosensory and motor cortices.
RESULTS: GABA concentration is reduced in children with ADHD compared with typically developing control subjects.
CONCLUSION: Our finding of reduced GABA concentration in ADHD is concordant with recently reported deficits in short intracortical inhibition in ADHD and suggests a GABAergic deficit in ADHD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22752239      PMCID: PMC3970207          DOI: 10.1001/archgenpsychiatry.2011.2280

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  22 in total

1.  Dorsolateral prefrontal γ-aminobutyric acid in men predicts individual differences in rash impulsivity.

Authors:  Frederic Boy; C John Evans; Richard A E Edden; Andrew D Lawrence; Krish D Singh; Masud Husain; Petroc Sumner
Journal:  Biol Psychiatry       Date:  2011-07-14       Impact factor: 13.382

2.  Genetic modulation of GABA levels in the anterior cingulate cortex by GAD1 and COMT.

Authors:  Stefano Marenco; Antonina A Savostyanova; Jan Willem van der Veen; Matthew Geramita; Alexa Stern; Alan S Barnett; Bhaskar Kolachana; Eugenia Radulescu; Fengyu Zhang; Joseph H Callicott; Richard E Straub; Jun Shen; Daniel R Weinberger
Journal:  Neuropsychopharmacology       Date:  2010-03-31       Impact factor: 7.853

3.  Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings.

Authors:  R T Brown; W S Freeman; J M Perrin; M T Stein; R W Amler; H M Feldman; K Pierce; M L Wolraich
Journal:  Pediatrics       Date:  2001-03       Impact factor: 7.124

4.  Diurnal stability of gamma-aminobutyric acid concentration in visual and sensorimotor cortex.

Authors:  Christopher John Evans; David John McGonigle; Richard Anthony Edward Edden
Journal:  J Magn Reson Imaging       Date:  2010-01       Impact factor: 4.813

5.  Individual differences in subconscious motor control predicted by GABA concentration in SMA.

Authors:  Frederic Boy; C John Evans; Richard A E Edden; Krish D Singh; Masud Husain; Petroc Sumner
Journal:  Curr Biol       Date:  2010-09-30       Impact factor: 10.834

6.  Motor cortex inhibition: a marker of ADHD behavior and motor development in children.

Authors:  D L Gilbert; K M Isaacs; M Augusta; L K Macneil; S H Mostofsky
Journal:  Neurology       Date:  2011-02-15       Impact factor: 9.910

Review 7.  Attention deficit hyperactivity disorder: advances in cognitive, neurobiological, and genetic research.

Authors:  R Tannock
Journal:  J Child Psychol Psychiatry       Date:  1998-01       Impact factor: 8.982

8.  Regionally specific human GABA concentration correlates with tactile discrimination thresholds.

Authors:  Nicolaas A J Puts; Richard A E Edden; C John Evans; Francis McGlone; David J McGonigle
Journal:  J Neurosci       Date:  2011-11-16       Impact factor: 6.167

9.  Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples.

Authors:  J Biederman; S V Faraone; K Keenan; J Benjamin; B Krifcher; C Moore; S Sprich-Buckminster; K Ugaglia; M S Jellinek; R Steingard
Journal:  Arch Gen Psychiatry       Date:  1992-09

10.  A self-report measure of pubertal status: Reliability, validity, and initial norms.

Authors:  A C Petersen; L Crockett; M Richards; A Boxer
Journal:  J Youth Adolesc       Date:  1988-04
View more
  94 in total

1.  Macromolecule-suppressed GABA-edited magnetic resonance spectroscopy at 3T.

Authors:  Richard A E Edden; Nicolaas A J Puts; Peter B Barker
Journal:  Magn Reson Med       Date:  2012-07-06       Impact factor: 4.668

2.  Binocular rivalry transitions predict inattention symptom severity in adult ADHD.

Authors:  Aiste Jusyte; Natalia Zaretskaya; Nina Maria Höhnle; Andreas Bartels; Michael Schönenberg
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-04-13       Impact factor: 5.270

3.  Big GABA: Edited MR spectroscopy at 24 research sites.

Authors:  Mark Mikkelsen; Peter B Barker; Pallab K Bhattacharyya; Maiken K Brix; Pieter F Buur; Kim M Cecil; Kimberly L Chan; David Y-T Chen; Alexander R Craven; Koen Cuypers; Michael Dacko; Niall W Duncan; Ulrike Dydak; David A Edmondson; Gabriele Ende; Lars Ersland; Fei Gao; Ian Greenhouse; Ashley D Harris; Naying He; Stefanie Heba; Nigel Hoggard; Tun-Wei Hsu; Jacobus F A Jansen; Alayar Kangarlu; Thomas Lange; R Marc Lebel; Yan Li; Chien-Yuan E Lin; Jy-Kang Liou; Jiing-Feng Lirng; Feng Liu; Ruoyun Ma; Celine Maes; Marta Moreno-Ortega; Scott O Murray; Sean Noah; Ralph Noeske; Michael D Noseworthy; Georg Oeltzschner; James J Prisciandaro; Nicolaas A J Puts; Timothy P L Roberts; Markus Sack; Napapon Sailasuta; Muhammad G Saleh; Michael-Paul Schallmo; Nicholas Simard; Stephan P Swinnen; Martin Tegenthoff; Peter Truong; Guangbin Wang; Iain D Wilkinson; Hans-Jörg Wittsack; Hongmin Xu; Fuhua Yan; Chencheng Zhang; Vadim Zipunnikov; Helge J Zöllner; Richard A E Edden
Journal:  Neuroimage       Date:  2017-07-14       Impact factor: 6.556

4.  EEG power spectral slope differs by ADHD status and stimulant medication exposure in early childhood.

Authors:  Madeline M Robertson; Sarah Furlong; Bradley Voytek; Thomas Donoghue; Charlotte A Boettiger; Margaret A Sheridan
Journal:  J Neurophysiol       Date:  2019-10-16       Impact factor: 2.714

Review 5.  Edited 1 H magnetic resonance spectroscopy in vivo: Methods and metabolites.

Authors:  Ashley D Harris; Muhammad G Saleh; Richard A E Edden
Journal:  Magn Reson Med       Date:  2017-02-02       Impact factor: 4.668

6.  Impulsivity and Aggression in Female BPD and ADHD Patients: Association with ACC Glutamate and GABA Concentrations.

Authors:  Gabriele Ende; Sylvia Cackowski; Julia Van Eijk; Markus Sack; Traute Demirakca; Nikolaus Kleindienst; Martin Bohus; Esther Sobanski; Annegret Krause-Utz; Christian Schmahl
Journal:  Neuropsychopharmacology       Date:  2015-06-04       Impact factor: 7.853

7.  Hyperactivity in mice lacking one allele of the glutamic acid decarboxylase 67 gene.

Authors:  Karen Müller Smith
Journal:  Atten Defic Hyperact Disord       Date:  2018-03-19

8.  Relationship among Glutamine, γ-Aminobutyric Acid, and Social Cognition in Autism Spectrum Disorders.

Authors:  David M Cochran; Elif M Sikoglu; Steven M Hodge; Richard A E Edden; Ann Foley; David N Kennedy; Constance M Moore; Jean A Frazier
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-04-28       Impact factor: 2.576

9.  Edited magnetic resonance spectroscopy detects an age-related decline in brain GABA levels.

Authors:  Fei Gao; Richard A E Edden; Muwei Li; Nicolaas A J Puts; Guangbin Wang; Cheng Liu; Bin Zhao; Huiquan Wang; Xue Bai; Chen Zhao; Xin Wang; Peter B Barker
Journal:  Neuroimage       Date:  2013-04-13       Impact factor: 6.556

Review 10.  ADHD is associated with migraine: a systematic review and meta-analysis.

Authors:  Haitham Salem; David Vivas; Fei Cao; Iram F Kazimi; Antonio L Teixeira; Cristian P Zeni
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-09-13       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.